Eur Rev Med Pharmacol Sci 2020; 24 (4): 2162-2164

DOI: 10.26355/eurrev_202002_20396

Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?

A. Perrella, N. Carannante, M. Berretta, M. Rinaldi, N. Maturo, L. Rinaldi

VII Division of Infectious Diseases and Immunology, P.O. “D. Cotugno”, AORN Ospedali dei Colli, Naples, Italy. lucarinaldi@hotmail.it

Free PDF Download

To cite this article

A. Perrella, N. Carannante, M. Berretta, M. Rinaldi, N. Maturo, L. Rinaldi
Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 4
Pages: 2162-2164
DOI: 10.26355/eurrev_202002_20396

Keywords Related articles:

  1. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV
  2. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?
  3. Editorial – Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents
  4. Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection
  5. COVID-19 (Novel Coronavirus 2019) – recent trends